Aethlon CEO Interview

Interview on National Public Radio with Jim Joyce, CEO of Aethlon Medical and Executive Chairman of Exosome Sciences. Its blood test appears to identify CTE – Chronic Traumatic Encephalopathy – in retired NFL players.

The interview is quite informative as it provides the historic backdrop of their exosome research, references their first data in Alzheimer’s disease and discusses a forthcoming study of Chronic Traumatic Encephalopathy (CTE) in former NFL players that will be conducted by their Exosome Sciences subsidiary.

Leave a Reply

Your email address will not be published. Required fields are marked *